Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$97.11
Market cap
$194.15B
P/E Ratio
11.25
Dividend/share
$7.52
EPS
$8.63
Enterprise value
$212.7B
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world
Highlights
The company's EPS has surged by 131% YoY and by 9% QoQ
The company's net income has surged by 125% YoY and by 9% QoQ
The company's debt rose by 28% YoY and by 11% QoQ
Key stats
What are the main financial stats of NVS
Market
Valuations
Earnings
Shares outstanding
2B
Market cap
$194.15B
Enterprise value
$212.7B
Price to earnings (P/E)
11.25
Price to book (P/B)
4.54
Price to sales (P/S)
3.91
EV/EBIT
10.89
EV/EBITDA
N/A
EV/Sales
4.26
Revenue
$49.94B
Gross profit
$37.42B
Net income
$17.6B
EBIT
$19.53B
EBITDA
N/A
Free cash flow
$14.96B
Per share
Balance sheet
Liquidity
EPS
$8.63
EPS diluted
$8.58
Free cash flow per share
$7.44
Book value per share
$21.4
Revenue per share
$24.82
TBVPS
$25.19
Total assets
$103.52B
Total liabilities
$60.08B
Debt
$32.16B
Equity
$43.32B
Working capital
$3.13B
Debt to equity
0.74
Current ratio
1.11
Quick ratio
0.78
Net debt/EBITDA
N/A
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
74.9%
Net margin
35.2%
Operating margin
27.2%
Return on assets
17.8%
Return on equity
41.1%
Return on invested capital
52.4%
Return on capital employed
25.9%
Return on sales
39.1%
Dividend yield
7.74%
DPS
$7.52
Payout ratio
87.1%
NVS stock price
How has the Novartis AG stock price performed over time
Intraday
0.35%
1 week
-1.27%
1 month
-5.8%
1 year
-0.03%
YTD
-3.82%
QTD
-15.57%
Financial performance
How have Novartis AG's revenue and profit performed over time
Revenue
$49.94B
Gross profit
$37.42B
Operating income
$13.6B
Net income
$17.6B
Gross margin
74.9%
Net margin
35.2%
The company's net income has surged by 125% YoY and by 9% QoQ
The company's net margin has surged by 106% YoY and by 6% QoQ
NVS's operating income has soared by 52% year-on-year and by 16% since the previous quarter
NVS's operating margin is up by 39% year-on-year and by 13% since the previous quarter
Growth
What is Novartis AG's growth rate over time
Valuation
What is Novartis AG stock price valuation
P/E
11.25
P/B
4.54
P/S
3.91
EV/EBIT
10.89
EV/EBITDA
N/A
EV/Sales
4.26
The company's EPS has surged by 131% YoY and by 9% QoQ
The stock's P/E is 41% less than its 5-year quarterly average of 19.0 and 17% less than its last 4 quarters average of 13.5
NVS's P/B is 16% above its 5-year quarterly average of 3.9 but 9% below its last 4 quarters average of 5.0
The company's equity rose by 14% YoY and by 3.8% QoQ
The P/S is 11% less than the last 4 quarters average of 4.4 and 7% less than the 5-year quarterly average of 4.2
Novartis AG's revenue has increased by 9% YoY and by 2.2% QoQ
Efficiency
How efficient is Novartis AG business performance
NVS's ROE has soared by 163% YoY and by 6% QoQ
Novartis AG's ROA has soared by 158% YoY and by 11% from the previous quarter
The ROIC has soared by 106% year-on-year
The company's return on sales has surged by 84% YoY and by 7% QoQ
Dividends
What is NVS's dividend history
DPS
$7.52
Dividend yield
7.74%
Payout ratio
87.1%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Novartis AG financials performed over time
NVS's total assets is 72% greater than its total liabilities
The quick ratio has soared by 95% year-on-year and by 30% since the previous quarter
Novartis AG's current ratio has increased by 19% QoQ and by 18% YoY
The company's debt is 26% lower than its equity
The company's debt rose by 28% YoY and by 11% QoQ
The company's equity rose by 14% YoY and by 3.8% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.